Telo Genomics Corp. (TSXV:TELO)

Canada flag Canada · Delayed Price · Currency is CAD
0.1150
+0.0050 (4.55%)
Jul 2, 2025, 9:30 AM EDT
-37.84%
Market Cap 11.50M
Revenue (ttm) n/a
Net Income (ttm) -2.61M
Shares Out 100.02M
EPS (ttm) -0.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 14,500
Average Volume 41,071
Open 0.1150
Previous Close 0.1150
Day's Range 0.1150 - 0.1150
52-Week Range 0.0700 - 0.2300
Beta 0.09
RSI 64.24
Earnings Date Sep 26, 2025

About Telo Genomics

Telo Genomics Corp., a molecular diagnostics company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions primarily in Canada. Its TeloView platform measures the 3D structure and spatial organization of telomeres to inform on genetic and molecular characteristics that are predictive of genomic instability to identify specific disease mechanisms, predict disease risks, and determine effective treatments. Its lead product is TeloView-SMM (Smolde... [Read more]

Sector Healthcare
CEO Sabine Mai
Employees 6
Stock Exchange TSX Venture Exchange
Ticker Symbol TELO
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.